PURPOSE OF REVIEW: The review aims at reviewing the evidence published in the peer review literature or otherwise available with particular focus on articles published over the last 2 years on the transurethral needle ablation of the prostate in the treatment of benign prostatic hyperplasia. Prospective noncomparative and comparative studies as well as meta-analyses were considered. Information from the European Real Life database on transurethral needle ablation was also included. RECENT FINDINGS: The evidence currently available confirms a clinically relevant improvement of lower urinary tract symptoms and quality of life. Impact on voiding dynamics including flow rates, detrusor pressure at maximum flow and postvoid residual, as well on prostate volume, remains marginal. SUMMARY: All major guidelines in the management of lower urinary tract symptoms in patients with benign prostatic enlargement include transurethral needle ablation of the prostate as a valuable treatment option in patients with severe symptoms and low degree of bladder outlet obstruction, patients at high risk for surgery and patients who wish to avoid surgery or regional/general anaesthesia. © 2007 Lippincott Williams & Wilkins, Inc.

Tubaro, A., De Nunzio, C., Miano, R. (2007). Transurethral needle ablation of the prostate. CURRENT OPINION IN UROLOGY, 17(1), 7-11 [10.1097/MOU.0b013e328011ab98].

Transurethral needle ablation of the prostate

MIANO, ROBERTO
2007-01-01

Abstract

PURPOSE OF REVIEW: The review aims at reviewing the evidence published in the peer review literature or otherwise available with particular focus on articles published over the last 2 years on the transurethral needle ablation of the prostate in the treatment of benign prostatic hyperplasia. Prospective noncomparative and comparative studies as well as meta-analyses were considered. Information from the European Real Life database on transurethral needle ablation was also included. RECENT FINDINGS: The evidence currently available confirms a clinically relevant improvement of lower urinary tract symptoms and quality of life. Impact on voiding dynamics including flow rates, detrusor pressure at maximum flow and postvoid residual, as well on prostate volume, remains marginal. SUMMARY: All major guidelines in the management of lower urinary tract symptoms in patients with benign prostatic enlargement include transurethral needle ablation of the prostate as a valuable treatment option in patients with severe symptoms and low degree of bladder outlet obstruction, patients at high risk for surgery and patients who wish to avoid surgery or regional/general anaesthesia. © 2007 Lippincott Williams & Wilkins, Inc.
2007
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/24 - UROLOGIA
English
Con Impact Factor ISI
Benign prostatic hyperplasia; Minimally invasive treatment; Prostatic hyperplasia; Transurethral needle ablation
Tubaro, A., De Nunzio, C., Miano, R. (2007). Transurethral needle ablation of the prostate. CURRENT OPINION IN UROLOGY, 17(1), 7-11 [10.1097/MOU.0b013e328011ab98].
Tubaro, A; De Nunzio, C; Miano, R
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/43353
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 3
social impact